• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

Mediobanca’s top investor Del Vecchio seeks more clout

September 29, 2021 by David Barret Leave a Comment

September 29, 2021

By Elisa Anzolin and Valentina Za

MILAN (Reuters) – Mediobanca’s top investor Leonardo Del Vecchio has proposed changing the Italian merchant bank’s by-laws to give more power to its board and shareholders over executives, but said he was not pushing for management or board changes.

Two years ago, Italian eyewear billionaire Del Vecchio rocked Italy’s financial establishment by emerging as the biggest investor in Mediobanca, the Milanese bank that used to pull the strings of Italy Inc.

Del Vecchio, 86, one of Italy’s richest men, has been steadily increasing his Mediobanca holding after gaining a green light from the European Central Bank. He now owns 18.9%, a stake currently worth 1.7 billion euros ($2 billion), through his holding company Delfin.

Delfin said it had no plans to push to replace Mediobanca’s current board or management.

The proposed governance changes aim to ensure Mediobanca’s managers and directors pursue “the creation of value for all shareholders … and ultimately leave the right to directors and shareholders … to decide who should run the bank.”

Mediobanca acknowledged the proposal in a note and said it would a hold board meeting in the coming days.

Delfin said it wanted Mediobanca to ditch a requirement in its by-laws stating that two or three directors – depending on the size of the board – must be executives who have held that role for at least three years.

Delfin also said it wanted the board to have more independent directors picked from at least two slates of nominees submitted by minority investors.

“We expect the market to favour the first proposal … but the second proposal could have a less market-friendly outcome,” Citi analyst Azzura Guelfi said, noting the influence of other minority investors could be limited if Delfin proposes one of the slates.

Del Vecchio has no representatives on Mediobanca’s board, which expires when the bank approves results to June 30, 2023.

After initially criticising the strategy of boss Alberto Nagel when he started buying Mediobanca shares, Del Vecchio has praised Nagel’s latest business plan presented in November 2019.

In the past, Del Vecchio and Nagel have locked horns over a project for a Milanese hospital. They also have diverging views over Generali, Italy’s biggest insurer.

Mediobanca, the single largest investor in Generali, is pushing to reappoint current CEO Philippe Donnet. Generali’s board endorsed that move on Monday.

Del Vecchio, the third-largest shareholder in Generali, is part of an investor pact pushing for a change of CEO and strategy.

Earlier on Tuesday, Italy’s Benetton family, like Del Vecchio an investor in both Mediobanca and Generali, said it wanted to keep a neutral stance in relation to all of its investments.

By 0753 GMT shares in Mediobanca were up 1.3%, outperforming Milan’s blue-chip index.

($1 = 0.8537 euros)

(Reporting by Elisa Anzolin and Valentina Za; Additional reporting by Gianluca Semeraro; Writing by Valentina Za; Editing by David Gregorio and Mark Potter)

Source Link Mediobanca’s top investor Del Vecchio seeks more clout

David Barret
David Barret

Related posts:

  1. Malaysia holiday hotspot readies for reopening with tourism bubble
  2. Popular Netflix series sparks new debate over S.Korea’s military conscription
  3. Tennis-Greek Sakkari boosts chances of making WTA Finals cut
  4. Georgian ex-president says he will fly home, despite jail threat, to ‘save the country’

Filed Under: News

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

  • An Alien-Like Fish With A See-Through Head And Green Eyes Lurks In The Ocean’s Dark Depths
  • Africa Wants To Change Misleading World Map, The “Wow!” Signal Was Likely From An Extraterrestrial Source, And Much More This Week
  • A “Good Death”: How Do Doctors Want To Die?
  • People Are Throwing Baby Puffins Off Cliffs In Iceland Again – But Why?
  • Yet Another Ancient Human Skull Turns Out To Be Denisovan
  • Gen Z Might Not Be On Course For A Midlife Crisis – Good News, Right? Wrong
  • Glowing Plants, Punk Ankylosaur, And Has The Wow! Signal Been Solved?
  • Pulsar Fleeing A Supernova Spotted Where Neither Of Them Should Be
  • 20 Years After Hurricane Katrina: Is It Time For A New Approach To Hurricane Classification?
  • Dog Named Scribble Replicates Quantum Factorization Records – So We Tried It Too
  • How Old Is The Solar System? (And How Can We Tell?)
  • Next Week, A Record-Breaking Over 7 Billion People Will See The Total Lunar Eclipse
  • The Goblin Shark Has The Fastest Jaws In The Ocean, Firing Like A Slingshot At Speeds Of 3.1-Meters-Per-Second
  • We Thought Geological Boundaries Were Random. Now, A New Study Has Identified Hidden Patterns
  • Do Fish Sleep?
  • The Biblical Flood Myth That Inspired Noah’s Ark Had A Sinister Twist
  • Massive Review Of 19 Autism Therapies Finds No Strong Evidence And Lack Of Safety Data
  • Giant City-Swallowing Cracks In Earth’s Surface Are A “New Geo-Hydrological Hazard”
  • Three Incredible Telescopes Looked At The Butterfly Nebula To Learn Where Earth Came From
  • The Pacific Ocean Is So Vast It Contains Its Own Antipodes
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2025 · Medical Market Report. All Rights Reserved.

Go to mobile version